Company Profile

Alliance Pharma plc is a United Kingdom-based international consumer healthcare company. The principal activity of the Company is to act as a holding company. The principal activity of the Company is the acquisition, marketing and distribution of consumer healthcare and pharmaceutical products. Its segments include Consumer Healthcare brands and Prescription Medicines. Its Consumer Healthcare brands include the Kelo-Cote franchise, Amberen, Nizoral, MacuShield, Aloclair, Vamousse, and other consumer healthcare brands. Its Prescription Medicines include Hydromol, Flamma Franchise, Forceval and other prescription medicines. Its products include Aloclair Plus Gel, Aloclair Plus Spray, Aloclair Plus Mouthwash, Anbesol Adult Strength Gel, Anbesol Teething Gel, Anbesol Liquid, Atopiclair Cream, and Atopiclair Lotion. It holds marketing rights to around 80 consumer healthcare brands and prescription medicines, which are sold worldwide in more than 100 countries.

Employees

290

Sector

Pharmaceuticals

More about the company

05-15	Alliance Pharma Delists from London Bourse's AIM After Acquisition	MT
05-14	Aegros Bidco Completes Takeover of Alliance Pharma	MT
05-14	Alliance Pharma Says Aegros Bidco Recommends Acquisition Of Alliance Pharma	RE
05-13	Alliance Pharma plc Announces the Termination of Camillo Pane as Director, Effective May 14, 2025	CI
05-13	Alliance Pharma plc Announces the Termination of Mr. Richard Alexander Mckenzie as Director, Effective from May 14, 2025	CI
05-13	Alliance Pharma Plc Announces the Termination of Martin Sutherland as Director, Effective May 14, 2025	CI
05-13	Alliance Pharma plc Announces the Termination of Kristof Leon Neirynck as Director, Effective from May 14, 2025	CI
05-13	Alliance Pharma plc Announces the Termination of Richard Crispin Jones as Director, Effective from May 14, 2025	CI
05-13	Alliance Pharma Plc Announces the Termination of Eva-Lotta Saga Sjostedt as Director, Effective May 14, 2025	CI
05-13	An undisclosed funds, managed by DBAY Advisors Limited, An undisclosed funds, managed by Baring Asset Management Limited, Edmond De Rothschild Equity Strategies IV Fund, a fund managed by Edmond de Rothschild Private Equity Management Ltd. and an undisclosed buyer completed the acquisition of remaining 71.9% stake in Alliance Pharma plc from Andrew Franklin, Richard Jones, Nick Sedgwick, Slater Investments Limited and others.	CI
05-13	Aegros' Takeover of Alliance Pharma Sanctioned by Court	MT
04-29	Slater Investments Discloses 4.37% Stake In Alliance Pharma As Of 25-Apr-2025	RE
04-08	Alliance Pharma loss narrows in 2024 due to reduced impairment charges	AN

17/03/23	Peel Hunt Starts Alliance Pharma at Hold	MT
15/06/22	Berenberg Begins Alliance Pharma Coverage With Buy Rating	MT
15/06/22	Analyst recommendations: Apple, Garmin, HSBC, Robinhood, Snowflake....
29/03/21	ALLIANCE PHARMA : RBC Initiates Alliance Pharma at Outperform	MT

05-09	Form 8.3 - [ALLIANCE PHARMA PLC - 08 05 2025] - (CGWL)	AQ
05-07	Form 8.3 - [ALLIANCE PHARMA PLC - 06 05 2025] - (CGWL)	AQ
04-29	Form 8.3 - [ALLIANCE PHARMA PLC - 28 04 2025] - (CGWL)	AQ
04-22	Form 8.3 - [ALLIANCE PHARMA PLC - 17 04 2025] - (CGWL)	AQ
04-17	Form 8.3 - [ALLIANCE PHARMA PLC - 16 04 2025] - (CGWL)	AQ

01-10	Les actions en mouvement : Ambu rehausse ses projections ; Ubisoft et OVH Group finissent mal la semaine
08/05/24	Bourse: l'Europe garde le cap, Wall Street moins dynamique
15/06/22	Bolsa de Madrid: La cuadratura del círculo
15/06/22	Avis d'analystes du jour : Airbus, Amundi, Kering, Logitech, Roche, Essity, Akzo Nobel, Rolls-Royce...
15/06/22	La quadrature du cercle

Manager	Title	Age	Since
Andrew Franklin DFI	Director of Finance/CFO	59	27/09/2015
Cora McCallum IRC	Investor Relations Contact	-	31/12/2021
Julie Skinner HRO	Human Resources Officer	-	31/10/2023

Alliance Pharma plc Share Price

Equities

APH

GB0031030819

Pharmaceuticals

Chart: Alliance Pharma plc

Latest news: Alliance Pharma plc

Analysts' recommendations: Alliance Pharma plc

Press Releases: Alliance Pharma plc

News in other languages: Alliance Pharma plc

Managers and Directors: Alliance Pharma plc

Generic Pharmaceuticals

Company Profile

Director	Title	Age	Since
Andrew Franklin BRD	Director/Board Member	59	27/09/2015
Kristof Leon Neirynck BRD	Director/Board Member	47	30/11/2021
Martin Sutherland BRD	Director/Board Member	56	31/01/2023

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Change	5d. change	1-year change	3-years change	Capi.($)
ALLIANCE PHARMA PLC	-.--%	+0.15%	-	-	480M
SUN PHARMACEUTICAL INDUSTRIES LTD.	-0.71%	-1.44%	-0.45%	+73.69%	48.57B
OTSUKA HOLDINGS CO., LTD.	-1.84%	+3.56%	+1.11%	+103.71%	31.85B
SANDOZ GROUP AG	+1.19%	+1.73%	+51.80%	-	30.62B
CIPLA LIMITED	-0.01%	-0.69%	+1.51%	+36.35%	13.68B
ZYDUS LIFESCIENCES LIMITED	-0.46%	-1.17%	-4.76%	+125.29%	10.48B
SHENZHEN SALUBRIS PHARMACEUTICALS CO., LTD.	-2.12%	-2.18%	+80.70%	+86.50%	9.74B
KRKA, D. D.	-0.49%	-0.98%	+46.91%	+113.53%	7.21B
THE MEDICINES COMPANY	-.--%	+0.14%	-	-	6.79B
ONO PHARMACEUTICAL CO., LTD.	-1.80%	-4.43%	+19.45%	-36.45%	6.5B
Average	-0.62%	+0.12%	+24.54%	+71.80%	18.38B
Weighted average by Cap.	-0.59%	+1.19%	+17.79%	+79.02%